SCHEMBL7420224

SCHEMBL7420224

COC(=O)CCCc1cc2ccc(C(=O)OC)cc2n1Cc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
TP53 P04637 3/20 0.44
DPP4 P27487 2/20 0.41
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.38
TNF P01375 2/20 0.38
PLA2G2A P14555 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
CCR2 P41597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424836 0.94 MAPT (0.45) MAPTTP53DPP4MAPK1L3MBTL1
SCHEMBL8006723 0.92 MAPT (0.44) MAPTTP53DPP4MAPK1L3MBTL1
SCHEMBL7422231 0.88 MAPT (0.47) MAPTTP53DPP4MAPK1L3MBTL1
SCHEMBL7425637 0.86 MAPT (0.48) MAPTTP53DPP4MAPK1L3MBTL1
SCHEMBL5882680 0.81 MAPT (0.53) MAPTTP53DPP4MAPK1L3MBTL1
SCHEMBL5881804 0.76 LMNA (0.49) MAPTTP53MAPK1LMNAKDM4E
SCHEMBL4875898 0.76 PPARG (0.48) NPC1RAB9ACCR2
SCHEMBL7422217 0.76 CCR2 (0.46) DPP4MEN1KMT2AALDH1A1NPC1
SCHEMBL7421832 0.76 KDM4E (0.42) MAPTLMNAKDM4EALDH1A1HPGD
SCHEMBL7418922 0.76 PTGDR2 (0.41) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed